Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Norway / NCT04009421
Active, not recruiting Observational

Coronary Artery Plaque Burden in Stable Angina and Non-obstructive Coronary Artery Disease

NCT04009421 · tracked via the Priya Life Science Norway tracker
Sponsor
University of Bergen
Phase
Observational
Started
2018-02-15
Last updated
2023-11-29

Condition(s) studied

Coronary Artery DiseasePlaque, Atherosclerotic

Investigational drug(s) / intervention(s)

Coronary artery plaque assessment by CT coronary angiography QAngio CT RE

Coronary artery plaque assessment by CT coronary angiography QAngio CT RE: Assessment of segmental plaque volume and composition

Study summary

Non-obstructive coronary artery disease (CAD), particularly common in women, has been associated with impaired quality of life and risk of recurrent hospitalizations. Several studies have also demonstrated increased risk of incident acute coronary events and mortality.

The main objective of the project is to assess the association between coronary artery plaque features by coronary CT angiography and long term prognosis in a large unselected population undergoing CT coronary angiography due to stable angina and suspected myocardial ischemia from the Norwegian Registry for Invasive Cardiology (NORIC) diagnosed with non-obstructive CAD by coronary CT angiography.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Stable angina * Non-obstructive coronary artery disease by CT coronary angiography defined as \<50% stenosis (lumen diameter reduction) Exclusion Criteria: * Obstructive coronary artery disease * Unstable angina * Previous myocardial infarction, heart surgery or percutaneous coronary interventions

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Clinical Science, University of Bergen Bergen Norway

More University of Bergen trials in Norway

Screening and Stimulation Testing for Residual Secretion of Adrenal Steroid Hormones in Autoimmune Addison's Disease Active, not recruiting
Plaque Burden and Ischemia in MINOCA Recruiting
Virtual Darkness Theraphy for Agitation in Dementia Recruiting
A Brief Intervention for PTSD - BWRT Enrolling by invitation
Effect of Herring Oil Concentrate on LDL Cholesterol Concentration in Adults Active, not recruiting

Other trials for the same condition

Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study Active, not recruiting
Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study Active, not recruiting
Digital Long-term Follow-up of Patients With Coronary Artery Disease Recruiting
Ruling Out Coronary Artery Disease and Myocardial Injury by Biomarkers Active, not recruiting
Patient-reported Outcomes After Percutaneous Coronary Intervention Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04009421 on ClinicalTrials.gov ↗ ← All trials in Norway